September 2024

Securities Class Action Lawsuit Filed Against CrowdStrike Holdings, Inc. RADNOR, Pa., Sept. 04, 2024 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas against CrowdStrike Holdings, Inc. (“CrowdStrike”)…

Welcome to the Kentucky First Federal Bancorp Board of Directors, R. Clay Hulette! Get to Know R. Clay Hulette It’s official – R. Clay Hulette has been selected to join the board of directors at Kentucky First Federal Bancorp, a momentous occasion for the company and for Hulette himself. Serving until the annual meeting in…

National Leader in Online Homebuying Now Selling from the mid $600s at Villa Bellissima MANTECA, Calif., Sept. 4, 2024 Century Communities, Inc. (NYSE:CCS)—one of the nation’s largest homebuilders, an industry leader in online home sales, and the highest-ranked homebuilder on Newsweek’s list of America’s Most Trustworthy Companies 2024—announced that the company is now selling at…

Welcome to Bloom: The Ultimate Fusion of Style and Sensation at New York Fashion Week! Get ready for an unforgettable experience! Are you ready to witness a groundbreaking fusion of style and sensation at New York Fashion Week? Look no further, because Bloom is here to take over the city! This exclusive event, scheduled for…

Investor Alert: Orthofix Medical Inc. Class Action Reminder Upcoming Deadline to File Lead Plaintiff Motion LOS ANGELES, Sept. 04, 2024 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 21, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased…

Welcome to Daktronics First Quarter Fiscal Year 2025 Financial Results Conference Call Company Participants Carla Gatzke – Corporate Secretary Reece Kurtenbach – Chief Executive Officer Sheila Anderson – Chief Financial Officer and Treasurer Conference Call Participants Anja Soderstrom – Sidoti Mac Furst – Singular Research Operator: Thank you for standing by, and welcome to Daktronics…

Exciting Developments in the Field of Rare Disease Treatment Positive Results for REC-994 in the Treatment of Cerebral Cavernous Malformation Recursion Pharmaceuticals, Inc. has recently announced positive safety and tolerability data for REC-994 in the treatment of Cerebral Cavernous Malformation (CCM). This promising development has also shown a trend towards improvement in patients, bringing hope…